Terms: = Breast cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Treatment
215 results:
1. Identification of a Panel of miRNAs Associated with Resistance to Palbociclib and Endocrine Therapy.
Torrisi R; Vaira V; Giordano L; Fernandes B; Saltalamacchia G; Palumbo R; Carnaghi C; Basilico V; Gentile F; Masci G; De Sanctis R; Santoro A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338777
[TBL] [Abstract] [Full Text] [Related]
2. Integrative Pan-cancer Genomic and Transcriptomic Analyses of Refractory Metastatic cancer.
Pradat Y; Viot J; Yurchenko AA; Gunbin K; Cerbone L; Deloger M; Grisay G; Verlingue L; Scott V; Padioleau I; Panunzi L; Michiels S; Hollebecque A; Jules-Clément G; Mezquita L; Lainé A; Loriot Y; Besse B; Friboulet L; André F; Cournède PH; Gautheret D; Nikolaev SI
Cancer Discov; 2023 May; 13(5):1116-1143. PubMed ID: 36862804
[TBL] [Abstract] [Full Text] [Related]
3. p27kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer.
Mouron S; Bueno MJ; Muñoz M; Torres R; Rodríguez S; Apala JV; Silva J; Sánchez-Bayona R; Manso L; Guerra J; Rodriguez-Lajusticia L; Malon D; Malumbres M; Quintela-Fandino M
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36806942
[TBL] [Abstract] [Full Text] [Related]
4. Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative breast cancer.
Adams CM; Mitra R; Xiao Y; Michener P; Palazzo J; Chao A; Gour J; Cassel J; Salvino JM; Eischen CM
Cancer Discov; 2023 May; 13(5):1210-1229. PubMed ID: 36734633
[TBL] [Abstract] [Full Text] [Related]
5. Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis.
Mustafa Ali MK; Samhouri Y; Law JY; Khan C; Wegner R; Lee ST; Lister J
Breast Cancer; 2022 Nov; 29(6):1022-1031. PubMed ID: 35788963
[TBL] [Abstract] [Full Text] [Related]
6. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.
El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RP; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
Eur J Cancer; 2022 May; 167():133-141. PubMed ID: 35216870
[TBL] [Abstract] [Full Text] [Related]
7. NP-ALT, a Liposomal:Peptide Drug, Blocks p27kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant breast cancer Cells.
Jilishitz I; Quiñones JL; Patel P; Chen G; Pasetsky J; VanInwegen A; Schoninger S; Jogalekar MP; Tsiperson V; Yan L; Wu Y; Gottesman SRS; Somma J; Blain SW
Mol Cancer Res; 2021 Nov; 19(11):1929-1945. PubMed ID: 34446542
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
Vishnubalaji R; Alajez NM
Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3.
Sharma U; Barwal TS; Khandelwal A; Malhotra A; Rana MK; Singh Rana AP; Imyanitov EN; Vasquez KM; Jain A
Biochimie; 2021 Mar; 182():99-107. PubMed ID: 33429003
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative breast cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic.
Rojas-Jiménez E; Mejía-Gómez JC; Díaz-Velásquez C; Quezada-Urban R; Martínez Gregorio H; Vallejo-Lecuona F; de la Cruz-Montoya A; Porras Reyes FI; Pérez-Sánchez VM; Maldonado-Martínez HA; Robles-Estrada M; Bargalló-Rocha E; Cabrera-Galeana P; Ramos-Ramírez M; Chirino YI; Alonso Herrera L; Terrazas LI; Oliver J; Frecha C; Perdomo S; Vaca-Paniagua F
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33227964
[TBL] [Abstract] [Full Text] [Related]
11. Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer.
Ozates NP; Soğutlu F; Lerminoglu F; Demir B; Gunduz C; Shademan B; Avci CB
Life Sci; 2021 Jan; 264():118643. PubMed ID: 33141044
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
Helmberger T; Golfieri R; Pech M; Pfammatter T; Arnold D; Cianni R; Maleux G; Munneke G; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; de Jong N; Bilbao JI; ;
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):21-35. PubMed ID: 32959085
[TBL] [Abstract] [Full Text] [Related]
13. Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer.
Xue L; Chen F; Yue F; Camacho L; Kothapalli S; Wei G; Huang S; Mo Q; Ma F; Li Y; Jiralerspong S
Breast Cancer Res Treat; 2021 Jan; 185(1):73-84. PubMed ID: 32940848
[TBL] [Abstract] [Full Text] [Related]
14. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive breast cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
15. Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in breast cancer Cells.
El-Daly SM; Gamal-Eldeen AM; Gouhar SA; Abo-Elfadl MT; El-Saeed G
Appl Biochem Biotechnol; 2020 Dec; 192(4):1208-1223. PubMed ID: 32710170
[TBL] [Abstract] [Full Text] [Related]
16. miR‑135b‑5p enhances the sensitivity of HER‑2 positive breast cancer to trastuzumab via binding to cyclin D2.
Li Z; Qin Y; Chen P; Luo Q; Shi H; Jiang X
Int J Mol Med; 2020 Oct; 46(4):1514-1524. PubMed ID: 32700749
[TBL] [Abstract] [Full Text] [Related]
17. Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27
Chen Y; Du M; Yusuying S; Liu W; Tan Y; Xie P
Exp Cell Res; 2020 Jul; 392(2):112038. PubMed ID: 32360865
[TBL] [Abstract] [Full Text] [Related]
18. Determinants of quality of life in patients with incurable cancer.
Daly LE; Dolan RD; Power DG; Ní Bhuachalla É; Sim W; Cushen SJ; Fallon M; Simmons C; McMillan DC; Laird BJ; Ryan AM
Cancer; 2020 Jun; 126(12):2872-2882. PubMed ID: 32267548
[TBL] [Abstract] [Full Text] [Related]
19. VCP/p97 targets the nuclear export and degradation of p27
Shi X; Zhu K; Ye Z; Yue J
FASEB J; 2020 Apr; 34(4):5193-5207. PubMed ID: 32067276
[TBL] [Abstract] [Full Text] [Related]
20. Identification of FOXE3 transcription factor as a potent oncogenic factor in triple-negative breast cancer.
Wang H; Yang T; Yuan Y; Sun X
Biochem Biophys Res Commun; 2020 Feb; 523(1):78-85. PubMed ID: 31831170
[TBL] [Abstract] [Full Text] [Related]
[Next]
